Trending...
- Databricks Acquires BladeBridge Technology and Talent to Accelerate Data Warehouse Migrations USA - English India - English - 135
- Kelvin Emtech and Colm Engineering Unveil Strategic Joint Venture, to Boost Data Center and Building M&E Capabilities
- Interpreters Unlimited and Diya Health Introduce AI-Powered Interpretation and Translation
SAN JOSE, Calif. - Californer -- CPC announces the completion of a rigorous four-day audit conducted by Australia's Therapeutic Goods Administration (TGA), the country's government authority responsible for evaluating, assessing, and monitoring approved products defined as therapeutic goods. As a globally recognized peptide and oligonucleotide manufacturer, with our facilities built and operated to WHO GMP, FDA 21 CFR 210/211, and ICH Q7 standards, this audit marks a significant milestone in the company's ongoing commitment to ensuring the highest standards of quality and compliance. Our manufacturing facility in Hangzhou, China, was awarded an A2 compliance rating. This inspection certifies Good Manufacturing Practice (GMP) compliance of three commercial peptide active pharmaceutical ingredients (APIs). This achievement underscores our commitment to maintaining the highest quality standards in peptide production and ensures that our products meet stringent international regulatory requirements.
More on The Californer
About CPC Scientific.
Founded in 2001, we are the third largest peptide-focused contract research, development, and manufacturing organization ("CRDMO") worldwide in the of terms of sales revenue in 2023, according to Frost & Sullivan. We are also considered one of the most comprehensive peptide-focused CRDMO globally (Frost & Sullivan), offering complete life-cycle support from early-discovery, pre-clinical research and clinical development to commercial production.
Our operations in China are conducted in our facility located at No. 69, Street 12 of Qiantang District, Hangzhou ("Qiantang Site"), situated on our approximately 26,000 square meter CGMP campus. The constructed manufacturing CGMP facility has a gross floor area ("GFA") of over 15,000 square meters. Our production facilities adhere rigorously to CGMP as mandated by major regulatory authorities globally, including the U.S. Food and Drug Administration ("FDA"), National Medical Products Administration ("NMPA"), European Medicines Agency ("EMA"), Therapeutic Goods Administration ("TGA"), and Korean Ministry of Food and Drug Safety ("MFDA"). We have successfully passed four FDA audits without receiving FDA-483 observations (FDA notice highlighting regulatory violations found during an inspection) as of the Latest Practicable Date ("LPD"). In addition, our facility holds ISO9001 and ISO13485 certifications for quality management systems.
More on The Californer
In addition to the Qiantang Site, we also have GMP production facilities under construction in the United States and Hangzhou, China, with a total GFA of 4,000 and 26,700 square meters, respectively. All our production facilities are equipped with advanced equipment and instrumentation supplied by top-tier equipment suppliers such as Agilent, Waters, Thermo Fisher, Cytiva, Jianbang, and Hanbang.
website
More on The Californer
- Epic Pictures' DREAD Label Hits the Market with Horror-Comedy For Sale By Exorcist
- RE1 Advisor Expands Services to Texas
- Wonderfront Music & Arts Festival Announces 2025 Lineup Featuring: Anderson .Paak & The Free Nationals, Khruangbin, Peggy Gou, Daniel Caesar, Foster the People, Jason Mraz, Gary Clark Jr., Janelle Monae, Portugal. The Man, Isaiah Rashad, Duke Dumo
- Dr. Angela Butts Chester Named a Top 100 B2B Thought Leader by Thinkers360 for 2025
- Parentis Foundation Launches Literacy Leaders Giving Circle to Advance Youth Literacy
About CPC Scientific.
Founded in 2001, we are the third largest peptide-focused contract research, development, and manufacturing organization ("CRDMO") worldwide in the of terms of sales revenue in 2023, according to Frost & Sullivan. We are also considered one of the most comprehensive peptide-focused CRDMO globally (Frost & Sullivan), offering complete life-cycle support from early-discovery, pre-clinical research and clinical development to commercial production.
Our operations in China are conducted in our facility located at No. 69, Street 12 of Qiantang District, Hangzhou ("Qiantang Site"), situated on our approximately 26,000 square meter CGMP campus. The constructed manufacturing CGMP facility has a gross floor area ("GFA") of over 15,000 square meters. Our production facilities adhere rigorously to CGMP as mandated by major regulatory authorities globally, including the U.S. Food and Drug Administration ("FDA"), National Medical Products Administration ("NMPA"), European Medicines Agency ("EMA"), Therapeutic Goods Administration ("TGA"), and Korean Ministry of Food and Drug Safety ("MFDA"). We have successfully passed four FDA audits without receiving FDA-483 observations (FDA notice highlighting regulatory violations found during an inspection) as of the Latest Practicable Date ("LPD"). In addition, our facility holds ISO9001 and ISO13485 certifications for quality management systems.
More on The Californer
- Open Wide Legacy Dental Clinic Announces 2025 Volunteer Schedule In Guatemala
- Uhland Pop Shop Launches February 11, 2025, Bringing Local Pride to Uhland, TX
- Partnerships to Launch Digital Entertainment Hub in China; $40 Million Investment into Global MOBA Digital Game Arena: NIP Group (Stock Symbol: NIPG)
- Most Reliable Vehicles of 2025
- Sip Social Co. Brings Refreshing Energy to the Miami Marathon Finish Festival with FP Movement
In addition to the Qiantang Site, we also have GMP production facilities under construction in the United States and Hangzhou, China, with a total GFA of 4,000 and 26,700 square meters, respectively. All our production facilities are equipped with advanced equipment and instrumentation supplied by top-tier equipment suppliers such as Agilent, Waters, Thermo Fisher, Cytiva, Jianbang, and Hanbang.
website
Source: CPC Scientific Inc.
0 Comments
Latest on The Californer
- The ROS1ders Issues RFA for $75K ROS1+ Cancer Research Grant
- Black Iris III Social Club (BISC)
- BARRE3 ACCELERATES GROWTH WITH STRATEGIC STUDIO BARRE ACQUISITION
- California: Governor Newsom sponsors legislation to provide interest for disaster-affected homeowners
- Harness and Traceable Announce Merger to Shape the Future of AI-Driven Software Delivery
- Hawaii Bill Marks Progress in Protecting Patients From Dangerous Restraint Practices
- All me - secure anonymous social - kickstarter crowdfunding
- Caroline Klebl Launches Innovative Yoga Teacher Training App for Flexible Learning & Certification
- HomeFortis Launches Target Hardening Guides for Home Security
- Church of Scientology Premieres "The Question" During Super Bowl LIX
- Retired Leadership Facilitator Shares Decades of Wisdom in New Book
- Alander Lee Pulliam, Authored Businessman, Sues Usc Transportation Department For Defamation
- UCLA Researchers Develop AI-Powered Sensor for High-Sensitivity Cardiac Diagnostics
- Call for Boycott Google- For Its DEI Cave to Trump
- NIH Slashes Research Funding Impacting Universities Everywhere
- Southland Symphony Presents SSO Soloists!
- I belong (t)here, an exhibition that explores the fluidity of identity and the search for belonging in a world that is constantly shifting
- Milwaukee 2727-21HDB M18 FUEL Brushless 16 in. Chainsaw & Blower 12Ah Kit
- California: Governor Newsom announces appointments 2.7.25
- California: Governor Newsom signs legislation 2.7.25